AddLife AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
July 14, 2023 at 01:45 am EDT
Share
AddLife AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 2,365 million compared to SEK 2,079 million a year ago. Net income was SEK 33 million compared to SEK 74 million a year ago. Basic earnings per share from continuing operations was SEK 0.27 compared to SEK 0.63 a year ago. Diluted earnings per share from continuing operations was SEK 0.27 compared to SEK 0.62 a year ago.
For the six months, sales was SEK 4,822 million compared to SEK 4,658 million a year ago. Net income was SEK 206 million compared to SEK 299 million a year ago. Basic earnings per share from continuing operations was SEK 1.7. Diluted earnings per share from continuing operations was SEK 1.7 compared to SEK 2.46 a year ago.
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
ADDLIFE AB 
